Use of SAM2® biotin capture membrane in microarrayed compound screening (μARCS) format for nucleic acid polymerization assays

Xiaoling Xuei, Caroline A. David, Tim R. Middleton, Ben Lim, Ron Pithawalla, Chih Ming Chen, Rakesh L. Tripathi, David J. Burns, Usha Warrior

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Microarrayed compound screening format (μARCS) is a novel high-throughput screening technology that uses agarose matrices to integrate various biochemical or biological reagents in the assay. To evaluate the feasibility of using the μARCS technology for nucleic acid polymerization assays, the authors developed HIV reverse transcription (RT) and E1-dependent human papillomavirus (HPV) replication assays in this format. HIV RT is an RNA-dependent DNA polymerase, whereas HPV E1 is a DNA helicase. To ensure the efficient capture of the nucleic acid polymerization reaction and to minimize the nonspecific binding, the authors used a SAM2® biotin capture membrane in the assay. In both studies, the nucleic acid substrate was biotinylated on one end and was bound to the SAM2® membrane. A low melting-point agarose gel containing the rest of the reaction components was first placed on a polystyrene sheet spotted with compounds to allow passive diffusion of the compounds into the gel. The gel was removed from the compound sheet and applied to the SAM2® membrane with the immobilized nucleic acid template to initiate the polymerization. After the incubation, the membrane was washed with a high-salt buffer and exposed for imaging. Potential inhibitors can be seen as white spots on a dark background. The sensitivity for the known inhibitors appears to be comparable in μARCS as in a traditional 96-well plate assay. The methodology described in this paper further expands the applications of μARCS technology.

Original languageEnglish
Pages (from-to)273-282
Number of pages10
JournalJournal of Biomolecular Screening
Volume8
Issue number3
DOIs
StatePublished - Jun 2003

Fingerprint

Biotin
Polymerization
Nucleic Acids
Assays
Screening
Membranes
Gels
Technology
Sepharose
Reverse Transcription
Transcription
Immobilized Nucleic Acids
HIV
DNA Helicases
RNA-Directed DNA Polymerase
Polystyrenes
Dental Caries
Freezing
Buffers
Salts

Keywords

  • μARCS
  • High-throughput screening
  • Nucleic acid polymerization assays
  • SAM®

ASJC Scopus subject areas

  • Analytical Chemistry
  • Clinical Biochemistry
  • Biotechnology
  • Biochemistry
  • Molecular Biology

Cite this

Use of SAM2® biotin capture membrane in microarrayed compound screening (μARCS) format for nucleic acid polymerization assays. / Xuei, Xiaoling; David, Caroline A.; Middleton, Tim R.; Lim, Ben; Pithawalla, Ron; Chen, Chih Ming; Tripathi, Rakesh L.; Burns, David J.; Warrior, Usha.

In: Journal of Biomolecular Screening, Vol. 8, No. 3, 06.2003, p. 273-282.

Research output: Contribution to journalArticle

Xuei, Xiaoling ; David, Caroline A. ; Middleton, Tim R. ; Lim, Ben ; Pithawalla, Ron ; Chen, Chih Ming ; Tripathi, Rakesh L. ; Burns, David J. ; Warrior, Usha. / Use of SAM2® biotin capture membrane in microarrayed compound screening (μARCS) format for nucleic acid polymerization assays. In: Journal of Biomolecular Screening. 2003 ; Vol. 8, No. 3. pp. 273-282.
@article{cc90fd45605045dd811dfcbbcee286ab,
title = "Use of SAM2{\circledR} biotin capture membrane in microarrayed compound screening (μARCS) format for nucleic acid polymerization assays",
abstract = "Microarrayed compound screening format (μARCS) is a novel high-throughput screening technology that uses agarose matrices to integrate various biochemical or biological reagents in the assay. To evaluate the feasibility of using the μARCS technology for nucleic acid polymerization assays, the authors developed HIV reverse transcription (RT) and E1-dependent human papillomavirus (HPV) replication assays in this format. HIV RT is an RNA-dependent DNA polymerase, whereas HPV E1 is a DNA helicase. To ensure the efficient capture of the nucleic acid polymerization reaction and to minimize the nonspecific binding, the authors used a SAM2{\circledR} biotin capture membrane in the assay. In both studies, the nucleic acid substrate was biotinylated on one end and was bound to the SAM2{\circledR} membrane. A low melting-point agarose gel containing the rest of the reaction components was first placed on a polystyrene sheet spotted with compounds to allow passive diffusion of the compounds into the gel. The gel was removed from the compound sheet and applied to the SAM2{\circledR} membrane with the immobilized nucleic acid template to initiate the polymerization. After the incubation, the membrane was washed with a high-salt buffer and exposed for imaging. Potential inhibitors can be seen as white spots on a dark background. The sensitivity for the known inhibitors appears to be comparable in μARCS as in a traditional 96-well plate assay. The methodology described in this paper further expands the applications of μARCS technology.",
keywords = "μARCS, High-throughput screening, Nucleic acid polymerization assays, SAM{\circledR}",
author = "Xiaoling Xuei and David, {Caroline A.} and Middleton, {Tim R.} and Ben Lim and Ron Pithawalla and Chen, {Chih Ming} and Tripathi, {Rakesh L.} and Burns, {David J.} and Usha Warrior",
year = "2003",
month = "6",
doi = "10.1177/1087057103008003005",
language = "English",
volume = "8",
pages = "273--282",
journal = "Journal of Biomolecular Screening",
issn = "1087-0571",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Use of SAM2® biotin capture membrane in microarrayed compound screening (μARCS) format for nucleic acid polymerization assays

AU - Xuei, Xiaoling

AU - David, Caroline A.

AU - Middleton, Tim R.

AU - Lim, Ben

AU - Pithawalla, Ron

AU - Chen, Chih Ming

AU - Tripathi, Rakesh L.

AU - Burns, David J.

AU - Warrior, Usha

PY - 2003/6

Y1 - 2003/6

N2 - Microarrayed compound screening format (μARCS) is a novel high-throughput screening technology that uses agarose matrices to integrate various biochemical or biological reagents in the assay. To evaluate the feasibility of using the μARCS technology for nucleic acid polymerization assays, the authors developed HIV reverse transcription (RT) and E1-dependent human papillomavirus (HPV) replication assays in this format. HIV RT is an RNA-dependent DNA polymerase, whereas HPV E1 is a DNA helicase. To ensure the efficient capture of the nucleic acid polymerization reaction and to minimize the nonspecific binding, the authors used a SAM2® biotin capture membrane in the assay. In both studies, the nucleic acid substrate was biotinylated on one end and was bound to the SAM2® membrane. A low melting-point agarose gel containing the rest of the reaction components was first placed on a polystyrene sheet spotted with compounds to allow passive diffusion of the compounds into the gel. The gel was removed from the compound sheet and applied to the SAM2® membrane with the immobilized nucleic acid template to initiate the polymerization. After the incubation, the membrane was washed with a high-salt buffer and exposed for imaging. Potential inhibitors can be seen as white spots on a dark background. The sensitivity for the known inhibitors appears to be comparable in μARCS as in a traditional 96-well plate assay. The methodology described in this paper further expands the applications of μARCS technology.

AB - Microarrayed compound screening format (μARCS) is a novel high-throughput screening technology that uses agarose matrices to integrate various biochemical or biological reagents in the assay. To evaluate the feasibility of using the μARCS technology for nucleic acid polymerization assays, the authors developed HIV reverse transcription (RT) and E1-dependent human papillomavirus (HPV) replication assays in this format. HIV RT is an RNA-dependent DNA polymerase, whereas HPV E1 is a DNA helicase. To ensure the efficient capture of the nucleic acid polymerization reaction and to minimize the nonspecific binding, the authors used a SAM2® biotin capture membrane in the assay. In both studies, the nucleic acid substrate was biotinylated on one end and was bound to the SAM2® membrane. A low melting-point agarose gel containing the rest of the reaction components was first placed on a polystyrene sheet spotted with compounds to allow passive diffusion of the compounds into the gel. The gel was removed from the compound sheet and applied to the SAM2® membrane with the immobilized nucleic acid template to initiate the polymerization. After the incubation, the membrane was washed with a high-salt buffer and exposed for imaging. Potential inhibitors can be seen as white spots on a dark background. The sensitivity for the known inhibitors appears to be comparable in μARCS as in a traditional 96-well plate assay. The methodology described in this paper further expands the applications of μARCS technology.

KW - μARCS

KW - High-throughput screening

KW - Nucleic acid polymerization assays

KW - SAM®

UR - http://www.scopus.com/inward/record.url?scp=1542754165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542754165&partnerID=8YFLogxK

U2 - 10.1177/1087057103008003005

DO - 10.1177/1087057103008003005

M3 - Article

VL - 8

SP - 273

EP - 282

JO - Journal of Biomolecular Screening

JF - Journal of Biomolecular Screening

SN - 1087-0571

IS - 3

ER -